Published in Cancer Weekly, August 31st, 2004
The company also announced that James S. Burns, EntreMed president and CEO, has joined the company's board of directors.
The company reported a net loss for the second quarter of 2004 of $4.2 million, or $0.12 per share. This compares with a net loss of $5.3 million, or $0.19 per share, for the same period last year. Revenues for the second quarter 2004 were approximately $139,000 versus $286,000 for the comparable period a year ago.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.